188 related articles for article (PubMed ID: 23552467)
1. Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines.
Rettew AN; Young ED; Lev DC; Kleinerman ES; Abdul-Karim FW; Getty PJ; Greenfield EM
Oncogenesis; 2012 Nov; 1(11):e34. PubMed ID: 23552467
[TBL] [Abstract][Full Text] [Related]
2. Receptor Tyrosine Kinases in Osteosarcoma: 2019 Update.
Greenfield EM; Collier CD; Getty PJ
Adv Exp Med Biol; 2020; 1258():141-155. PubMed ID: 32767239
[TBL] [Abstract][Full Text] [Related]
3. Receptor tyrosine kinases in osteosarcoma: not just the usual suspects.
Rettew AN; Getty PJ; Greenfield EM
Adv Exp Med Biol; 2014; 804():47-66. PubMed ID: 24924168
[TBL] [Abstract][Full Text] [Related]
4. Receptor Tyrosine Kinases in Osteosarcoma Treatment: Which Is the Key Target?
Tian Z; Niu X; Yao W
Front Oncol; 2020; 10():1642. PubMed ID: 32984034
[TBL] [Abstract][Full Text] [Related]
5. Specific tyrosine kinase inhibitors regulate human osteosarcoma cells in vitro.
Messerschmitt PJ; Rettew AN; Brookover RE; Garcia RM; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2008 Sep; 466(9):2168-75. PubMed ID: 18607665
[TBL] [Abstract][Full Text] [Related]
6. Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.
Collier CD; Wirtz EC; Knafler GJ; Morris WZ; Getty PJ; Greenfield EM
Clin Orthop Relat Res; 2018 Jul; 476(7):1400-1411. PubMed ID: 29481344
[TBL] [Abstract][Full Text] [Related]
7. Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.
Chaiyawat P; Klangjorhor J; Settakorn J; Champattanachai V; Phanphaisarn A; Teeyakasem P; Svasti J; Pruksakorn D
Transl Oncol; 2017 Oct; 10(5):846-853. PubMed ID: 28881260
[TBL] [Abstract][Full Text] [Related]
8. Activation and function of receptor tyrosine kinases in human clear cell renal cell carcinomas.
Zhang Q; Liu JH; Liu JL; Qi CT; Yan L; Chen Y; Yu Q
BMC Cancer; 2019 Nov; 19(1):1044. PubMed ID: 31690270
[TBL] [Abstract][Full Text] [Related]
9. Leptocarpin Suppresses Proliferation, Migration, and Invasion of Human Osteosarcoma by Targeting Type-1 Insulin-Like Growth Factor Receptor (IGF-1R).
Zheng SW; Wan WG; Miao HX; Tang R; Wang B; Huang QZ; Liu WL; Zheng JP; Chen CQ; Zhong HB; Li SF; Sun CH
Med Sci Monit; 2017 Aug; 23():4132-4140. PubMed ID: 28844074
[TBL] [Abstract][Full Text] [Related]
10. Coactivation of receptor tyrosine kinases in malignant mesothelioma as a rationale for combination targeted therapy.
Brevet M; Shimizu S; Bott MJ; Shukla N; Zhou Q; Olshen AB; Rusch V; Ladanyi M
J Thorac Oncol; 2011 May; 6(5):864-74. PubMed ID: 21774103
[TBL] [Abstract][Full Text] [Related]
11. Phosphoproteomic screen identifies potential therapeutic targets in melanoma.
Tworkoski K; Singhal G; Szpakowski S; Zito CI; Bacchiocchi A; Muthusamy V; Bosenberg M; Krauthammer M; Halaban R; Stern DF
Mol Cancer Res; 2011 Jun; 9(6):801-12. PubMed ID: 21521745
[TBL] [Abstract][Full Text] [Related]
12. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus-mediated RNAi knockdown of insulin-like growth factor-1 receptor inhibits growth, reduces invasion, and enhances radiosensitivity in human osteosarcoma cells.
Wang YH; Wang ZX; Qiu Y; Xiong J; Chen YX; Miao DS; De W
Mol Cell Biochem; 2009 Jul; 327(1-2):257-66. PubMed ID: 19229591
[TBL] [Abstract][Full Text] [Related]
14. Targeting receptor tyrosine kinases in osteosarcoma and Ewing sarcoma: current hurdles and future perspectives.
Fleuren ED; Versleijen-Jonkers YM; Boerman OC; van der Graaf WT
Biochim Biophys Acta; 2014 Apr; 1845(2):266-76. PubMed ID: 24582852
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.
Duan Z; Choy E; Harmon D; Yang C; Ryu K; Schwab J; Mankin H; Hornicek FJ
Mol Cancer Ther; 2009 Aug; 8(8):2122-30. PubMed ID: 19638450
[TBL] [Abstract][Full Text] [Related]
17. miR-199a-3p negatively regulates the progression of osteosarcoma through targeting AXL.
Tian R; Xie X; Han J; Luo C; Yong B; Peng H; Shen J; Peng T
Am J Cancer Res; 2014; 4(6):738-50. PubMed ID: 25520864
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
19. R1507, a fully human monoclonal antibody targeting IGF-1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts.
Kolb EA; Kamara D; Zhang W; Lin J; Hingorani P; Baker L; Houghton P; Gorlick R
Pediatr Blood Cancer; 2010 Jul; 55(1):67-75. PubMed ID: 20486173
[TBL] [Abstract][Full Text] [Related]
20. Multiple receptor tyrosine kinases are expressed in adult rat retinal ganglion cells as revealed by single-cell degenerate primer polymerase chain reaction.
Lindqvist N; Lönngren U; Agudo M; Näpänkangas U; Vidal-Sanz M; Hallböök F
Ups J Med Sci; 2010 Feb; 115(1):65-80. PubMed ID: 20187850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
